CV Sciences (CVSI) Cash from Operations (2011 - 2026)
CV Sciences (CVSI) posted Cash from Operations of 101000.0 for Q1 2026, up 133.67% sequentially from 300000.0 in Q4 2025, and up 224.69% YoY from 31106.46 in Q1 2025.
CV Sciences (CVSI) Cash from Operations (2011 - 2026) Analysis & Trends
CV Sciences has reported Cash from Operations for 16 years, with the latest figure at 101000.0 in Q1 2026.
- Quarterly Cash from Operations rose 224.69% year-over-year to 101000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 218000.0 (up 48.58% YoY) and the FY2025 annual result came in at 400000.0, up 53.54% from the prior year.
- Cash from Operations rose to 101000.0 in Q1 2026 per CVSI's latest filing, from 300000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 1411000.0 in Q2 2023 and troughed at 1169000.0 in Q2 2022.
- A 5-year average of 46588.24 and a median of 114000.0 in 2023 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2024 and 2025: Cash from Operations sank 542.11% in 2024, then soared 603.51% in 2025.
- Over 5 years, Cash from Operations stood at 210000.0 in 2022, then plunged by 154.29% to 114000.0 in 2023, then slumped by 43.86% to 164000.0 in 2024, then plunged by 82.93% to 300000.0 in 2025, then soared by 133.67% to 101000.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 101000.0, 300000.0, and 306000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn | 20,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20,000.00 |
| Jun 30, 2026 | 20,000.00 |
| Mar 31, 2026 | 101,000.00 |
| Mar 31, 2026 | 101,000.00 |
| Dec 31, 2025 | -300,000.00 |
| Dec 31, 2025 | -300,000.00 |
| Sep 30, 2025 | -306,000.00 |
| Sep 30, 2025 | -306,000.00 |
| Jun 30, 2025 | 287,000.00 |
| Jun 30, 2025 | 287,000.00 |
| Mar 31, 2025 | -81,000.00 |
| Mar 31, 2025 | -81,000.00 |
| Dec 31, 2024 | -164,000.00 |
| Dec 31, 2024 | -164,000.00 |
| Sep 30, 2024 | -122,000.00 |
| Sep 30, 2024 | -122,000.00 |
| Jun 30, 2024 | -57,000.00 |
| Jun 30, 2024 | -57,000.00 |
| Mar 31, 2024 | -518,000.00 |
| Mar 31, 2024 | -518,000.00 |